Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease
Increased body weight is independently associated with impaired clopidogrel pharmacodynamic (PD) response. Prasugrel has more potent PD effects compared with clopidogrel, although its PD effects in obese patients are unknown. The aim of this prospective, randomised, study was to compare the PD effec...
Saved in:
Published in | Thrombosis and haemostasis Vol. 111; no. 2; p. 258 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.02.2014
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!